PathHunter® Bevacizumab Bioassay HS Kit

The PathHunter® Bevacizumab Bioassay HS Kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay detects VEGF-A induced homodimeriziaton of the kinase insert domain (KDR), also known as VEGFR2 receptor.

View bioassay qualification data.

Catalog #: 93-0996Y1-00165

$1,989.00$9,979.00


Inquire
Biological Information
Background Information:
The PathHunter® Bevacizumab Bioassay HS Kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay detects VEGF-A induced Homodimeriziaton of the kinase insert domain (KDR), also known as VEGFR2 receptor. The included cells overexpress ProLink-tagged KDR/KDR and EA-tagged. Activation of KDR/KDR stimulates the recruitment of and produces EFC signal. This assay has been optimized and qualified with Avastin® (not supplied in the bioassay kit). Avastin® is a registered trademark of Genentech, Inc.. Bioassay kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, control agonist, detection reagent, and assay plates. The HS kit has been optimized to deliver reproducible results with lower variability.
Target Class:
Kinase
Family:
Receptor Typosine Kinase (RTK): Growth Factor Receptor
Accession Number:
NM_002253.2
Target Name:
KDR/KDR
Target Aliases:
Kinase Insert Domain Receptor, FLK1, CD309, VEGFR, VEGFR2
Target Species:
Human
Cell Background:
HEK293
Usage
Product Type:
Bioassay Kits
Application:
Potency; Commercial Release & Stability
Kit Components:
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Functional
Assay Measures:
Dimerization
Detection Method:
Chemiluminescence
Bioassay Data
Qualified With:
Avastin®
Trademark Statement:
Avastin® is a registered trademark of Genentech, Inc.
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
PathHunter®

User Manuals & Protocols

70-435 PathHunter Bevacizumab Bioassay HS Kit REV0 User Manual

View Document

Datasheets

93-0996Y1x Datasheet

View Document